% Expired Patents = 25.0

Trademarks = 2

Forward Citations = 24

Loading Chart...

12 inventors (with patents filed for the assignee):

Graham Johnson (3 out of 53 patents)

David E Nichols (3 out of 29 patents)

Claire Wombwell (3 out of 3 patents)

4. Daniel Rixson (3 out of 3 patents)

5. Peter Haddow (3 out of 3 patents)

6. Carrie Sheard (3 out of 3 patents)

7. Alexander Schwarz (3 out of 3 patents)

8. Hooshang Shahriari Zavareh (3 out of 9 patents)

9. J Cannon Clifton (1 out of 1 patent)

10. Mark Alan Moran (1 out of 1 patent)

11. John Bryan Clifton (1 out of 1 patent)

12. Scott Patrick Worrich (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12545642 - Pharmaceutically acceptable salts of psilocin and uses thereof (2026-02-10),

2. 11680043 - Pharmaceutically acceptable salts of psilocin and uses thereof (2023-06-20),

3. 11312684 - Pharmaceutically acceptable salts of psilocin and uses thereof (2022-04-26),

4. 11154537 - Method of treatment for ketamine infusion (2021-10-26),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#1,394 in New York, NY

#3,682 in New York

#60,671 in US

New York, NY, United States of America

Eleusis Therapeutics US, Inc.

Forward Citations = 24

12 inventors:

Graham Johnson (3 out of 53 patents)

David E Nichols (3 out of 29 patents)

Claire Wombwell (3 out of 3 patents)

4. Daniel Rixson (3 out of 3 patents)

5. Peter Haddow (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eleusis Therapeutics US, Inc.. Retrieved from https://idiyas.com/company/eleusis-therapeutics-us

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]